ArticleBreast (Edinburgh, Scotland)2020

A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan.

Vakaramoko Diaby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.